Activities

Categories

• Manufacturer
• Research structure

Expertise

CAR-T Cell

• Analytical Process, Quality assement, Quality Control
• Cleaning
• CGMP
• Cross contamination
• Sterility
• Deviations
• Quality control
• Contaminants detection
• Safety for gene-edited cells : translocation
• Safety for gene-edited cells : anti-nuclease response
• Safety for gene-edited cells : cytokine-independent growth
• Targer Identification
• Targer Identification
• Biomarker Identificaton
• Biomarker Identificaton
• Adoptive T cell Major Challenges in Solid Tumors
• Tumor/Ag heterogeneity
• Tumor associated Antigen
• Miroenvironment
• Delivery/homing
• Combinations
• Bioproduction
• Bioproduction
• Scale-Up
• Automate manufacturing
• Automated high-throughput microbioreactor system
• Supply chain logistics
• Tracking process
• Monitoring logistics
• Non-GMP pilot batch
• GMP batch
• Ex Vivo & In Vivo Strategy
• Ex Vivo & In Vivo Strategy
• Target cell isolation
• iPS reprogrammation
• Differentiated Cell
• Production Cell
• Safety donor-derived therapies
• Cell modification
• Gene modifcation
• Directed reprogrammation
• Construct introduction
• Cell Expansion
• Bioreacteur
• Wave
• Cell factory
• Other
• Purification / extraction
• Purification / extraction
Cell Therapy / Engineering

• Analytical Process, Quality assement, Quality Control
• Cleaning
• CGMP
• Cross contamination
• Sterility
• Deviations
• Quality control
• Contaminants detection
• Safety for gene-edited cells : translocation
• Safety for gene-edited cells : anti-nuclease response
• Safety for gene-edited cells : cytokine-independent growth
• Bioproduction
• Bioproduction
• Scale-Up
• Automate manufacturing
• Automated high-throughput microbioreactor system
• Supply chain logistics
• Tracking process
• Monitoring logistics
• Non-GMP pilot batch
• GMP batch
• Ex Vivo & In Vivo Strategy
• Ex Vivo & In Vivo Strategy
• Cell acquisition
• Autologus
• Allogenic
• Cell Bank
• Target cell isolation
• iPS reprogrammation
• Differentiated Cell
• Production Cell
• Safety donor-derived therapies
• Cell modification
• Directed reprogrammation
• Cell Activation
• Cell Expansion
• Bioreacteur
• Wave
• Cell factory
• Other